|
US4460577A
(en)
*
|
1977-09-30 |
1984-07-17 |
Farmitalia Carlo Erba S.P.A. |
Pharmaceutical compositions consisting or consisting essentially of liposomes, and processes for making same
|
|
US4356167A
(en)
*
|
1978-01-27 |
1982-10-26 |
Sandoz, Inc. |
Liposome drug delivery systems
|
|
DE2925009A1
(de)
*
|
1979-06-21 |
1981-01-08 |
Basf Ag |
Zubereitung fuer substanzen, verfahren zu deren herstellung und deren verwendung
|
|
CA1173360A
(en)
*
|
1979-06-22 |
1984-08-28 |
Jurg Schrank |
Pharmaceutical preparations
|
|
EP0032622B1
(en)
*
|
1979-12-20 |
1985-08-14 |
Dennis Chapman |
Polymerisable phospholipids and polymers thereof, methods for their preparation, methods for their use in coating substrates and forming liposomes and the resulting coated substrates and liposome compositions
|
|
US4933114A
(en)
*
|
1980-08-11 |
1990-06-12 |
Eastman Kodak Company |
Polyacetylenic lipids, radiation-sensitive compositions, photographic elements and processes relating to same
|
|
JPS5782310A
(en)
*
|
1980-11-11 |
1982-05-22 |
Tanabe Seiyaku Co Ltd |
Production of liposome preparation
|
|
NL193099C
(nl)
*
|
1981-10-30 |
1998-11-03 |
Novo Industri As |
Gestabiliseerde insuline-oplossing.
|
|
FR2521565B1
(fr)
*
|
1982-02-17 |
1985-07-05 |
Dior Sa Parfums Christian |
Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
|
|
US4425334A
(en)
|
1982-04-02 |
1984-01-10 |
The Regents Of The University Of California |
Functional oxygen transport system
|
|
US4612370A
(en)
*
|
1982-04-02 |
1986-09-16 |
The Regents Of The University Of California |
Lipid-saccharide reaction products
|
|
GB2135647A
(en)
*
|
1983-02-15 |
1984-09-05 |
Squibb & Sons Inc |
Method of preparing liposomes and products produced thereby
|
|
US5186941A
(en)
*
|
1983-05-06 |
1993-02-16 |
Vestar, Inc. |
Vesicle formulation for the controlled release of therapeutic agents
|
|
US4515736A
(en)
*
|
1983-05-12 |
1985-05-07 |
The Regents Of The University Of California |
Method for encapsulating materials into liposomes
|
|
JPS607932A
(ja)
*
|
1983-06-29 |
1985-01-16 |
Dai Ichi Seiyaku Co Ltd |
リポソーム懸濁液およびその製法
|
|
US4744989A
(en)
*
|
1984-02-08 |
1988-05-17 |
E. R. Squibb & Sons, Inc. |
Method of preparing liposomes and products produced thereby
|
|
US5141674A
(en)
*
|
1984-03-08 |
1992-08-25 |
Phares Pharmaceutical Research N.V. |
Methods of preparing pro-liposome dispersions and aerosols
|
|
JPS60239417A
(ja)
*
|
1984-05-15 |
1985-11-28 |
Sankyo Co Ltd |
エマルシヨン凍結乾燥製剤の製法
|
|
SE8403905D0
(sv)
*
|
1984-07-30 |
1984-07-30 |
Draco Ab |
Liposomes and steroid esters
|
|
CA1270198C
(en)
*
|
1984-08-08 |
1990-06-12 |
Marcel B Bally |
ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES
|
|
US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
|
US5736155A
(en)
*
|
1984-08-08 |
1998-04-07 |
The Liposome Company, Inc. |
Encapsulation of antineoplastic agents in liposomes
|
|
EP0208764A4
(en)
*
|
1985-01-11 |
1987-10-08 |
Univ California |
PRESERVATION PROCEDURE FOR LIPOSOME.
|
|
US4857319A
(en)
*
|
1985-01-11 |
1989-08-15 |
The Regents Of The University Of California |
Method for preserving liposomes
|
|
US4830858A
(en)
*
|
1985-02-11 |
1989-05-16 |
E. R. Squibb & Sons, Inc. |
Spray-drying method for preparing liposomes and products produced thereby
|
|
IE58981B1
(en)
*
|
1985-10-15 |
1993-12-15 |
Vestar Inc |
Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
|
|
US4806343A
(en)
*
|
1986-03-13 |
1989-02-21 |
University Of Southwestern Louisiana |
Cryogenic protectant for proteins
|
|
SE8601457D0
(sv)
*
|
1986-04-01 |
1986-04-01 |
Draco Ab |
Compositions of liposomes and b?712-receptor active substances for inhalation
|
|
US4839175A
(en)
*
|
1986-07-28 |
1989-06-13 |
Liposome Technology, Inc. |
Liposomes with enhanced retention on mucosal tissue
|
|
WO1988000824A1
(en)
*
|
1986-07-28 |
1988-02-11 |
Liposome Technology, Inc. |
Liposomes with enhanced retention on mucosal tissue
|
|
US4804539A
(en)
*
|
1986-07-28 |
1989-02-14 |
Liposome Technology, Inc. |
Ophthalmic liposomes
|
|
US4818537A
(en)
*
|
1986-10-21 |
1989-04-04 |
Liposome Technology, Inc. |
Liposome composition for treating dry eye
|
|
FR2634375B3
(fr)
*
|
1988-06-30 |
1991-07-05 |
Centre Nat Rech Scient |
Procede de preparation de systemes colloidaux dispersibles de lipide amphiphiles sous forme de liposomes submicroniques
|
|
US5089181A
(en)
*
|
1987-02-24 |
1992-02-18 |
Vestar, Inc. |
Method of dehydrating vesicle preparations for long term storage
|
|
JP2677647B2
(ja)
*
|
1987-02-24 |
1997-11-17 |
ネクスター・フアーマシユーテイカルズ・インコーポレイテツド |
リポリーム製剤の脱水方法
|
|
US6406713B1
(en)
|
1987-03-05 |
2002-06-18 |
The Liposome Company, Inc. |
Methods of preparing low-toxicity drug-lipid complexes
|
|
US5616334A
(en)
*
|
1987-03-05 |
1997-04-01 |
The Liposome Company, Inc. |
Low toxicity drug-lipid systems
|
|
US4863739A
(en)
*
|
1987-05-19 |
1989-09-05 |
Board Of Regents, The University Of Texas System |
Liposome compositions of anthracycline derivatives
|
|
AU617678B2
(en)
*
|
1987-05-22 |
1991-12-05 |
Liposome Company, Inc., The |
Prostaglandin-lipid formulations
|
|
US5262168A
(en)
*
|
1987-05-22 |
1993-11-16 |
The Liposome Company, Inc. |
Prostaglandin-lipid formulations
|
|
US5925375A
(en)
*
|
1987-05-22 |
1999-07-20 |
The Liposome Company, Inc. |
Therapeutic use of multilamellar liposomal prostaglandin formulations
|
|
US4963362A
(en)
*
|
1987-08-07 |
1990-10-16 |
Regents Of The University Of Minnesota |
Freeze-dried liposome mixture containing cyclosporin
|
|
US4950432A
(en)
*
|
1987-10-16 |
1990-08-21 |
Board Of Regents, The University Of Texas System |
Polyene microlide pre-liposomal powders
|
|
US5178875A
(en)
*
|
1991-01-14 |
1993-01-12 |
The Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
|
US5830498A
(en)
*
|
1987-10-16 |
1998-11-03 |
Board Of Regents, The University Of Texas System |
Liposomal-polyene preliposomal powder and method for its preparation
|
|
MX9203804A
(es)
*
|
1987-10-19 |
1992-07-01 |
Liposome Co Inc |
Sistemas farmaceuticos a base de tocoferol.
|
|
WO1989006654A1
(en)
*
|
1988-01-19 |
1989-07-27 |
Board Of Regents, The University Of Texas System |
Glycosides, liposomal compositions thereof, and methods for their use
|
|
JPH01160962U
(US06277897-20010821-C00009.png)
*
|
1988-04-28 |
1989-11-08 |
|
|
|
US5096629A
(en)
*
|
1988-08-29 |
1992-03-17 |
501 Nippon Fine Chemical Co., Ltd. |
Method for preparing lipid powder for use in preparing liposomes and method for preparing liposomes
|
|
DE68916439T2
(de)
*
|
1988-10-05 |
1994-10-20 |
Vestar Inc |
Verfahren zur herstellung von liposomen mit verbesserter stabilität während des trocknens.
|
|
US4931361A
(en)
*
|
1988-11-18 |
1990-06-05 |
California Institute Of Technology |
Cryoprotective reagents in freeze-drying membranes
|
|
JP2807741B2
(ja)
*
|
1988-12-22 |
1998-10-08 |
コレチカ |
リポソームの安定化方法、安定化リポソーム組成物、ならびにそれを含む医薬組成物および化粧料組成物
|
|
US5585112A
(en)
*
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
|
US20020150539A1
(en)
|
1989-12-22 |
2002-10-17 |
Unger Evan C. |
Ultrasound imaging and treatment
|
|
US5305757A
(en)
*
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
US5776429A
(en)
*
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
|
US6001335A
(en)
*
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
|
US5469854A
(en)
*
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
|
US5733572A
(en)
*
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
|
US5656211A
(en)
*
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
|
US6088613A
(en)
*
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
|
US5882678A
(en)
*
|
1990-01-12 |
1999-03-16 |
The Liposome Co, Inc. |
Interdigitation-fusion liposomes containing arachidonic acid metabolites
|
|
US7083778B2
(en)
*
|
1991-05-03 |
2006-08-01 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
IN172208B
(US06277897-20010821-C00009.png)
*
|
1990-04-02 |
1993-05-01 |
Sint Sa |
|
|
US20040208826A1
(en)
*
|
1990-04-02 |
2004-10-21 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US5445813A
(en)
*
|
1992-11-02 |
1995-08-29 |
Bracco International B.V. |
Stable microbubble suspensions as enhancement agents for ultrasound echography
|
|
USRE39146E1
(en)
|
1990-04-02 |
2006-06-27 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US6613306B1
(en)
|
1990-04-02 |
2003-09-02 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US6989141B2
(en)
*
|
1990-05-18 |
2006-01-24 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
US5578292A
(en)
|
1991-11-20 |
1996-11-26 |
Bracco International B.V. |
Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
|
|
US20010024638A1
(en)
*
|
1992-11-02 |
2001-09-27 |
Michel Schneider |
Stable microbubble suspensions as enhancement agents for ultrasound echography and dry formulations thereof
|
|
AU636481B2
(en)
*
|
1990-05-18 |
1993-04-29 |
Bracco International B.V. |
Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography
|
|
US20030194376A1
(en)
*
|
1990-05-18 |
2003-10-16 |
Bracco International B.V. |
Ultrasound contrast agents and methods of making and using them
|
|
AU660288B2
(en)
*
|
1990-07-31 |
1995-06-22 |
Transave, Inc. |
Accumulation of amino acids and peptides into liposomes
|
|
US5556637A
(en)
*
|
1990-08-06 |
1996-09-17 |
A. Nattermann & Cie. Gmbh |
Water containing liposome system
|
|
US5874062A
(en)
*
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
|
IL104084A
(en)
*
|
1992-01-24 |
1996-09-12 |
Bracco Int Bv |
Sustainable aqueous suspensions of pressure-resistant and gas-filled blisters, their preparation, and contrast agents containing them
|
|
JP2711619B2
(ja)
*
|
1992-07-23 |
1998-02-10 |
理化学研究所 |
殺菌殺虫組成物
|
|
US5554730A
(en)
*
|
1993-03-09 |
1996-09-10 |
Middlesex Sciences, Inc. |
Method and kit for making a polysaccharide-protein conjugate
|
|
ES2113094T3
(es)
*
|
1993-03-09 |
1998-04-16 |
Epic Therapeutics Inc |
Las microparticulas macromoleculares y metodos de obtencion.
|
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
|
DK0699068T3
(da)
*
|
1993-05-21 |
2002-03-11 |
Liposome Co Inc |
Reduktion af liposominducerede fysiologiske bivirkninger
|
|
WO1995003035A1
(en)
*
|
1993-07-23 |
1995-02-02 |
Massachusetts Institute Of Technology |
Polymerized liposomes with enhanced stability for oral delivery
|
|
US6004534A
(en)
*
|
1993-07-23 |
1999-12-21 |
Massachusetts Institute Of Technology |
Targeted polymerized liposomes for improved drug delivery
|
|
AU680702B2
(en)
*
|
1993-10-25 |
1997-08-07 |
Transave, Inc. |
Liposomal defensins
|
|
DK0678017T3
(da)
|
1993-11-05 |
1998-10-19 |
Amgen Inc |
Liposomfremstilling og materialeindkapslingsfremgangsmåde
|
|
US7083572B2
(en)
|
1993-11-30 |
2006-08-01 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Therapeutic delivery systems
|
|
HU225495B1
(en)
*
|
1993-12-15 |
2007-01-29 |
Bracco Research Sa |
Gas mixtures useful as ultrasound contrast media
|
|
US5736121A
(en)
*
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
|
US6156337A
(en)
*
|
1994-07-08 |
2000-12-05 |
Opperbas Holding B.V. |
Method for high loading of vesicles with biopolymeric substances
|
|
US6066331A
(en)
*
|
1994-07-08 |
2000-05-23 |
Barenholz; Yechezkel |
Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
|
|
HU225964B1
(en)
*
|
1994-07-12 |
2008-01-28 |
Berwind Pharma Service |
Moisture barrier film coating composition, method, and coated form
|
|
DE4430592A1
(de)
*
|
1994-08-20 |
1996-02-22 |
Max Delbrueck Centrum |
Liposomale Zubereitung, ihre Herstellung und ihre Verwendung
|
|
US5589189A
(en)
*
|
1994-09-14 |
1996-12-31 |
Nexstar Pharmaceuticals, Inc. |
Liposome dispersion
|
|
IL115099A
(en)
*
|
1994-10-14 |
1999-04-11 |
Upjohn Co |
Lyophilizate of phospholipid complex of water insoluble camptothecins
|
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
|
US5830430A
(en)
*
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
|
US5997898A
(en)
*
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
|
US6139819A
(en)
*
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
|
US6033645A
(en)
*
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
|
US5855911A
(en)
*
|
1995-08-29 |
1999-01-05 |
Board Of Regents, The University Of Texas System |
Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
|
|
DE19605175A1
(de)
|
1996-02-13 |
1997-08-14 |
Sourovoi Andrej Dr |
Lipidverbindungen und deren Verwendung
|
|
US6015576A
(en)
*
|
1997-08-29 |
2000-01-18 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to an antigen
|
|
US6207185B1
(en)
|
1996-03-22 |
2001-03-27 |
Bio-Sphere Technology |
Method for inducing a systemic immune response to an HIV antigen
|
|
US6117449A
(en)
*
|
1996-03-22 |
2000-09-12 |
Bio-Sphere Technology, Inc. |
Method for inducing a systemic immune response to a hepatitis antigen
|
|
CA2174803C
(en)
*
|
1996-04-23 |
2000-07-11 |
Jonathan P. Wong |
Use of liposome encapsulated ciprofloxacin as an immunotherapeutic drug
|
|
CA2252617A1
(en)
|
1996-05-01 |
1997-11-06 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
|
US6093816A
(en)
*
|
1996-06-27 |
2000-07-25 |
Isis Pharmaceuticals, Inc. |
Cationic lipids
|
|
US7309692B1
(en)
*
|
1996-07-08 |
2007-12-18 |
Board Of Regents, The University Of Texas System |
Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
|
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
|
DK1323434T3
(da)
*
|
1996-09-11 |
2007-11-12 |
Bristol Myers Squibb Medical I |
Fremgangsmåde til diagnostisk billeddannelse af nyreregioner under anvendelse af et kontrastmiddel og en vasodilator
|
|
US6977244B2
(en)
|
1996-10-04 |
2005-12-20 |
Board Of Regents, The University Of Texas Systems |
Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
|
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
|
US6090800A
(en)
*
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
|
US6143276A
(en)
*
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
|
US6060082A
(en)
|
1997-04-18 |
2000-05-09 |
Massachusetts Institute Of Technology |
Polymerized liposomes targeted to M cells and useful for oral or mucosal drug delivery
|
|
US7452551B1
(en)
|
2000-10-30 |
2008-11-18 |
Imarx Therapeutics, Inc. |
Targeted compositions for diagnostic and therapeutic use
|
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
|
WO1999011242A1
(en)
*
|
1997-09-04 |
1999-03-11 |
Biozone Laboratories, Inc. |
Oral liposomal delivery system
|
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
|
US6046166A
(en)
|
1997-09-29 |
2000-04-04 |
Jean-Louis Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6037323A
(en)
*
|
1997-09-29 |
2000-03-14 |
Jean-Louis Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6518412B1
(en)
|
1997-09-29 |
2003-02-11 |
Jean-Louis Dasseux |
Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6004925A
(en)
|
1997-09-29 |
1999-12-21 |
J. L. Dasseux |
Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
|
|
US6033708A
(en)
*
|
1997-09-30 |
2000-03-07 |
The United States Of America As Represented By The Secretary Of The Navy |
Method for producing sterile filterable liposome dispersion
|
|
US6287590B1
(en)
|
1997-10-02 |
2001-09-11 |
Esperion Therapeutics, Inc. |
Peptide/lipid complex formation by co-lyophilization
|
|
US7704962B1
(en)
|
1997-10-03 |
2010-04-27 |
Board Of Regents, The University Of Texas System |
Small oligonucleotides with anti-tumor activity
|
|
US7285288B1
(en)
|
1997-10-03 |
2007-10-23 |
Board Of Regents, The University Of Texas System |
Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
|
|
US6123923A
(en)
*
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
|
GB9902527D0
(en)
*
|
1999-02-04 |
1999-03-24 |
Phares Pharm Res Nv |
Compositions
|
|
WO2001020999A1
(en)
*
|
1999-09-23 |
2001-03-29 |
Trimedyne, Inc. |
Materials and methods for inducing angiogenesis and the repair of mammalian tissue
|
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
|
US7282215B2
(en)
*
|
2000-05-08 |
2007-10-16 |
The University Of British Columbia |
Supports for photosensitizer formulations
|
|
IL155696A0
(en)
*
|
2000-11-09 |
2003-11-23 |
Neopharm Inc |
Sn-38 lipid complexes and methods of use
|
|
AU2002219998B2
(en)
*
|
2000-12-01 |
2006-03-02 |
Biomira, Inc. |
Preparation of large liposomes by infusion into peg
|
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
|
US20040043950A1
(en)
*
|
2002-01-03 |
2004-03-04 |
Board Of Regents, The University Of Texas System |
WT1 antisense oligos for the inhibition of breast cancer
|
|
US20030134423A1
(en)
*
|
2002-01-04 |
2003-07-17 |
Chu Yong Liang |
Compounds for delivering substances into cells
|
|
US20030219473A1
(en)
*
|
2002-03-26 |
2003-11-27 |
Leila Zarif |
Cochleates made with purified soy phosphatidylserine
|
|
US20030212046A1
(en)
*
|
2002-05-07 |
2003-11-13 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
|
|
US20060093661A1
(en)
|
2002-05-07 |
2006-05-04 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and gastro-intestinal bioavailability of hydrophobic drugs
|
|
CN1245153C
(zh)
*
|
2002-06-06 |
2006-03-15 |
上海家化联合股份有限公司 |
一种维生素a脂质体及其制备方法
|
|
WO2004035032A2
(en)
*
|
2002-08-20 |
2004-04-29 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
|
US20040247624A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
|
WO2006071659A1
(en)
*
|
2004-12-29 |
2006-07-06 |
Trustees Of Boston University |
Delivery of h2 antagonists
|
|
US20080094573A1
(en)
*
|
2006-04-04 |
2008-04-24 |
Vermette Patrick |
Surface-modified materials, such as contact lenses, methods and kits for their preparation, and uses thereof
|
|
WO2007137400A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Institut De Cardiologie De Montreal |
Method and compound for the treatment of valvular stenosis
|
|
ES2708851T3
(es)
*
|
2006-10-06 |
2019-04-11 |
Bionet Pharma Gmbh |
Un implante del núcleo pulposo espinal
|
|
US20080124387A1
(en)
|
2006-11-27 |
2008-05-29 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients
|
|
WO2008135828A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
|
US8703204B2
(en)
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
|
EP2162120B1
(en)
|
2007-06-04 |
2016-05-04 |
Bend Research, Inc |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
|
US20090088393A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Zomanex, Llc |
Methods and formulations for converting intravenous and injectable drugs into oral dosage forms
|
|
US20090092538A1
(en)
*
|
2007-10-08 |
2009-04-09 |
Amit Khanolkar |
Methods for forming stabilized metal salt particles
|
|
US9233078B2
(en)
|
2007-12-06 |
2016-01-12 |
Bend Research, Inc. |
Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer
|
|
EP2231169B1
(en)
|
2007-12-06 |
2016-05-04 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
|
SI2396017T1
(sl)
|
2009-02-16 |
2015-12-31 |
Cerenis Therapeutics Holding Sa |
Mimika apolipoproteina A-1
|
|
PL2445472T3
(pl)
|
2009-06-24 |
2018-07-31 |
Lipoid Gmbh |
Kompozycja do zastosowań kosmetycznych, farmaceutycznych lub dietetycznych
|
|
EP2394640A1
(en)
|
2010-05-21 |
2011-12-14 |
MediGene AG |
Improved liposomal formulations of lipophilic compounds
|
|
CN103200932A
(zh)
*
|
2010-06-23 |
2013-07-10 |
布莱特赛德创新有限公司 |
卵磷脂载体囊泡及其制备方法
|
|
JP2012102043A
(ja)
*
|
2010-11-10 |
2012-05-31 |
Konica Minolta Holdings Inc |
単胞リポソームの製造方法、単胞リポソームの分散液とその乾燥粉末及びそれらの製造方法
|
|
CN107206111B
(zh)
|
2014-12-31 |
2021-04-27 |
蓝瑟斯医学影像公司 |
脂质封装的气体微球组合物及相关方法
|
|
EP4166161A1
(en)
|
2016-04-14 |
2023-04-19 |
Fred Hutchinson Cancer Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
US10188749B2
(en)
|
2016-04-14 |
2019-01-29 |
Fred Hutchinson Cancer Research Center |
Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers
|
|
AU2017260532B2
(en)
|
2016-05-04 |
2024-08-22 |
Lantheus Medical Imaging, Inc. |
Methods and devices for preparation of ultrasound contrast agents
|
|
US9789210B1
(en)
|
2016-07-06 |
2017-10-17 |
Lantheus Medical Imaging, Inc. |
Methods for making ultrasound contrast agents
|
|
WO2018119274A1
(en)
|
2016-12-21 |
2018-06-28 |
Fred Hutchinson Cancer Research Center |
Scaffolds to treat solid tumor cells and escape variants
|
|
EP3565535A4
(en)
|
2017-01-05 |
2020-12-30 |
Fred Hutchinson Cancer Research Center |
SYSTEMS AND METHODS FOR IMPROVING THE EFFECTIVENESS OF A VACCINE
|
|
CA3143631A1
(en)
|
2019-06-20 |
2020-12-24 |
Janssen Sciences Ireland Unlimited Company |
Lipid nanoparticle or liposome delivery of hepatitis b virus (hbv) vaccines
|
|
TW202245809A
(zh)
|
2020-12-18 |
2022-12-01 |
美商詹森藥物公司 |
用於治療b型肝炎病毒感染之組合療法
|
|
WO2023233290A1
(en)
|
2022-05-31 |
2023-12-07 |
Janssen Sciences Ireland Unlimited Company |
Rnai agents targeting pd-l1
|
